Esophageal Large-Cell Neuroendocrine Carcinoma with Inconsistent Response to Treatment in the Primary and Metastatic Lesions
暂无分享,去创建一个
K. Okazaki | Toshihiro Tanaka | Chika Miyasaka | T. Tomiyama | Y. Ando | N. Danbara | Koh Nakamaru | T. Fukui | N. Fukata | R. Suzuki | T. Okazaki | M. Orino
[1] Hongfei Cai,et al. Progress in the treatment of esophageal neuroendocrine carcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[2] Long-Qi Chen,et al. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. , 2016, Journal of Thoracic Disease.
[3] D. Amadori,et al. First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma , 2015, OncoTargets and therapy.
[4] H. Kuriry,et al. Large-Cell Neuroendocrine Carcinoma of the Esophagus: A Case from Saudi Arabia , 2015, Case Reports in Gastroenterology.
[5] C. Chougnet,et al. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. , 2015, Endocrine-related cancer.
[6] Yeul-Hong Kim,et al. The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma. , 2014, Journal of gastrointestinal oncology.
[7] Ken Kato,et al. Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus. , 2014, Anticancer research.
[8] F. Gress,et al. A comprehensive review of esophageal stents. , 2012, Gastroenterology & hepatology.
[9] J. Summerall,et al. Esophageal collision tumor (Large cell neuroendocrine carcinoma and papillary carcinoma) arising in a Barrett esophagus. , 2009, Archives of pathology & laboratory medicine.
[10] K. Mori,et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. , 2002, The New England journal of medicine.
[11] I. Cecconello,et al. Primary neuroendocrine neoplasm of the esophagus - Report of 14 cases from a single institute and review of the literature. , 2017, Arquivos de gastroenterologia.
[12] T. Hibi,et al. Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literature. , 2013, Oncology letters.
[13] K Hirata,et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. , 1998, European journal of cancer.